| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
10% Owner | Director, 10% Owner | Director +2 more
43 companies
Ra Capital Management, L.P. is a Director, 10% Owner at WVE with holdings across 43 companies. Recent SEC Form 4 filings include 6 buys and 9 sells.
Estimated insider holdings value: $3503.7M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Sep 21, 2020 | DYN Dyne Therapeutics, Inc. | 10% Owner | Buy | 660,000 | $19.00 | $12,540,000.00 | +30.8% | |
| Sep 9, 2020 | TGTX Tg Therapeutics, Inc. | 10% Owner | Sell | 158,589 | $25.81 | $4,092,738.04 | -1.2% | |
| Jul 14, 2020 | NKTX Nkarta, Inc. | 10% Owner | Buy | 3,333,333 | $18.00 | $59,999,994.00 | +146.7% | |
| Jul 2, 2020 | RYTM Rhythm Pharmaceuticals, Inc. | 10% Owner | Sell | 131,581 | $22.06 | $2,902,517.12 | -0.8% | |
| Jun 29, 2020 | RYTM Rhythm Pharmaceuticals, Inc. | 10% Owner | Sell | 150,323 | $23.05 | $3,465,614.60 | -0.9% | |
| Jun 25, 2020 | VSTM Verastem, Inc. | 10% Owner | Sell | 1,161,300 | $1.91 | $2,219,941.08 | -6.7% | |
| Apr 27, 2020 | VSTM Verastem, Inc. | 10% Owner | Sell | 1,301,300 | $2.31 | $3,002,099.10 | -7.0% | |
| Apr 1, 2020 | PHAT Phathom Pharmaceuticals, Inc. | 10% Owner | Buy | 117,600 | $24.86 | $2,923,641.84 | +3.2% | |
| Mar 31, 2020 | PHAT Phathom Pharmaceuticals, Inc. | 10% Owner | Buy | 60,600 | $24.58 | $1,489,263.66 | +0.8% | |
| Mar 16, 2020 | ELVN Enliven Therapeutics, Inc. | 10% Owner | Buy | 625,000 | $16.00 | $10,000,000.00 | +75.4% |